FdaApplication
ANDA 210431
Identifiers
- fda_app_no: ANDA210431
Properties
| Property | Value |
|---|---|
| applicant_name | TORRENT PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2018-07-31 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MONTELUKAST SODIUM | MONTELUKAST SODIUM | EQ 4MG BASE/PACKET | GRANULE;ORAL |
1 product